AMGEN INC

Amgen insider buying signals confidence: EVP Santos Esteban, CEO Bradway and others purchased shares, boosting investor appeal amid a robust biotech pipeline and dividend outlook.

Amgen insider buying spikes: EVP & Gen Counsel Graham Jonathan P. adds 10,723 shares, signaling confidence in Amgen’s pipeline and dividend strategy amid market buzz.

Amgen’s EVP Santos Esteban’s February 2026 share buying signals executive confidence amid a near‑52‑week high, hinting at potential upside from upcoming product approvals.